Search Results

You are looking at 61 - 70 of 668 items for :

  • Refine by Access: All x
Clear All
Full access

Stacey Shiovitz and Keith D. Eaton

interpretation (T1, N1, M-oligo), her case was considered for treatment with curative intent for oligometastatic disease. The TNM staging guidelines for NSCLC were revised recently to account for better-understood prognostication based on disease involvement. 1

Full access

Al B. Benson III, Tanios Bekaii-Saab, Emily Chan, Yi-Jen Chen, Michael A. Choti, Harry S. Cooper, Paul F. Engstrom, Peter C. Enzinger, Marwan G. Fakih, Charles S. Fuchs, Jean L. Grem, Steven Hunt, Lucille A. Leong, Edward Lin, Michael G. Martin, Kilian Salerno May, Mary F. Mulcahy, Kate Murphy, Eric Rohren, David P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, William Small Jr, Constantinos T. Sofocleous, Alan P. Venook, Christopher G. Willett, Deborah A. Freedman-Cass, and Kristina M. Gregory

rectal cancer. These guidelines begin with the clinical presentation of the patient to the primary care physician or gastroenterologist, and go on to address diagnosis, pathologic staging, neoadjuvant treatment, surgical management, adjuvant treatment

Full access

Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Peter E. Clark, Tracy M. Downs, Jason A. Efstathiou, Thomas W. Flaig, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Noah Hahn, Harry W. Herr, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Joshua J. Meeks, Jeff Michalski, Jeffrey S. Montgomery, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker-Radtke, Guru Sonpavde, Jonathan Tward, Geoffrey Wile, Mary A. Dwyer, and Lisa A. Gurski

beyond the scope of these guidelines. Muscle-Invasive Urothelial Bladder Cancer Additional Workup Several workup procedures are recommended to accurately determine clinical staging of MIBC. Laboratory studies, such as a complete blood cell

Full access

Jason P. Wilson, David Mattson, and Stephen B. Edge

trial, combined with the results of the NSABP B-06 trials, changed the standard therapy from radical mastectomy to breast-conserving therapy, with axillary lymph node dissection (AND) performed for staging and local control. 2 In 1994, sentinel lymph

Full access

Jamie E. Flerlage, Susan M. Hiniker, Saro Armenian, Ellen C. Benya, Adam J. Bobbey, Vivian Chang, Stacy Cooper, Don W. Coulter, Branko Cuglievan, Bradford S. Hoppe, Leidy Isenalumhe, Kara Kelly, Leslie Kersun, Adam J. Lamble, Nicole A. Larrier, Jeffrey Magee, Kwadwo Oduro, Martha Pacheco, Anita P. Price, Kenneth B. Roberts, Christine M. Smith, Aliyah R. Sohani, Erin M. Trovillion, Emily Walling, Ana C. Xavier, Jennifer L. Burns, and Mallory Campbell

multidisciplinary panel of pediatric HL experts, with the goal of providing recommendations on standard treatment approaches based on current evidence. The NCCN Guidelines currently focus on clinical staging of CHL, and treatment strategies are adapted according to

Full access

Joseph G. Rajendran and Benjamin E. Greer

. Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer . Int J Gynecol Cancer 2002 ; 12 : 22 – 26 . 2. Goff BA Muntz HG Paley PJ . Impact of surgical staging in women with locally advanced cervical cancer

Full access

Bing-Yen Wang, Ping-Yi Lin, Shiao-Chi Wu, Hui-Shan Chen, Po-Kuei Hsu, Chih-Shiun Shih, Chao-Yu Liu, Chia-Chuan Liu, and Yao-Li Chen

post-CRT pathologic stage and patient outcome. Accurate staging systems play a critical role in cancer treatment. They also provide clinicians and patients with the means to predict survival and select optimal treatment modalities, tailored to disease

Full access

Christopher G. Willett

use of MRI is certainly not new, “there is more adoption of this now in staging. Pretty much all patients receive an MRI,” he said. MRI has an accuracy of up to 94% for T stage and up to 85% for N stage. 1 Neoadjuvant Therapy There is new

Full access

Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Don S. Dizon, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Ernest Han, Susan Higgins, Warner K. Huh, John R. Lurain III, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Stefanie Ueda, Fidel A. Valea, Emily Wyse, Catheryn M. Yashar, Nicole McMillian, and Jillian Scavone

and management of rare, non-SCC histologies. For the purposes of this discussion, vulvar SCC will generally be referred to as “vulvar cancer.” These guidelines utilize the FIGO and AJCC TNM staging systems, which closely align for the staging of

Full access

Brian Badgwell

) view/print certificate. Release date: October 10, 2016; Expiration date: October 10, 2017 Learning Objectives Upon completion of this activity, participants will be able to: Compare and contrast gastric cancer tumor biology, staging